PT-141 // FDA-Approved Libido Peptide
FDA-approved melanocortin receptor agonist that enhances sexual desire through central nervous system pathways — not blood flow. PT-141 targets desire itself at the hypothalamic level, making it fundamentally different from PDE5 inhibitors like Viagra. Works in both men and women.
Desire from the top down.
Viagra works on blood flow. PT-141 works on desire. The melanocortin system in the hypothalamus regulates sexual arousal at the CNS level — PT-141 activates MC3R and MC4R receptors to enhance the brain's own sexual response signaling.
On-demand, 45 minutes before activity.
PT-141 is used as-needed — not daily. The FDA-approved dose is 1.75mg subcutaneous, administered at least 45 minutes before anticipated sexual activity. Maximum one dose per 24 hours, no more than 8 doses per month.
From Melanotan to FDA approval.
PT-141 was derived from Melanotan II research — when subjects reported significant increases in sexual arousal as a 'side effect' of the tanning peptide. The sexual enhancement was isolated to the MC3R/MC4R pathway and developed into a standalone compound.
Phase 3 trials (RECONNECT) in premenopausal women with HSDD demonstrated statistically significant improvements in sexual desire, arousal, and distress scores compared to placebo. The FDA approved bremelanotide (Vyleesi) in June 2019.
Male studies showed efficacy in erectile dysfunction, particularly in patients who didn't respond to PDE5 inhibitors — suggesting a desire-based component to their dysfunction that PT-141 uniquely addresses. Off-label male use is widespread in the peptide community.
Sexual enhancement comparison.
| Compound | Mechanism | Target | Onset | Status |
|---|---|---|---|---|
| PT-141 | MC3R/MC4R (CNS) | Desire | ~45 min | FDA Approved |
| Sildenafil (Viagra) | PDE5 Inhibitor | Blood Flow | ~30 min | FDA Approved |
| Melanotan II | MC1-5R (Broad) | Tan + Libido | Days | Research |
| Kisspeptin-10 | GnRH Upstream | Testosterone | Variable | Research |
What to watch for.
PT-141's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
- Nausea (most common — 40% in trials, usually mild and transient)
- Flushing (vasodilation effect)
- Headache
- Injection site reactions
- Transient blood pressure increase (monitor if hypertensive)
- Skin hyperpigmentation with repeated use (melanocortin effect)
- Do not use with uncontrolled hypertension
- Max 8 doses per month per FDA labeling
- Blood pressure monitoring (before and after first use)
- Comprehensive metabolic panel
- Hormone panel (testosterone, estrogen — baseline)
- Liver enzymes (ALT, AST)
- No specific ongoing blood work required for on-demand use
- Kisspeptin-10 for upstream testosterone support alongside desire enhancement
- Do NOT combine with Melanotan II (overlapping melanocortin activity)
- Can be used alongside PDE5 inhibitors (different mechanisms)
- Gonadorelin/HCG for hormonal foundation if on TRT
- Anti-nausea strategies: lower dose, slower injection, ondansetron if needed
- On-demand use — no daily stacking required
- Lyophilized: refrigerate at 2–8°C (36–46°F)
- Reconstituted: refrigerate, use within 30 days
- Protect from light
- Do not freeze reconstituted solution
- Pharmaceutical Vyleesi autoinjector available by prescription
Compounds that complement PT-141.
The only FDA-approved peptide for sexual desire — and it actually works.
PT-141 solved a problem that Viagra never could: low desire. PDE5 inhibitors handle the plumbing; PT-141 handles the wanting. FDA approval with Phase 3 data in women, extensive off-label data in men, and a mechanism that targets the hypothalamic melanocortin system directly. The main barrier is nausea — about 40% of users experience it, though it's usually mild and improves with repeated use. Start with 1mg to test tolerance before the full 1.75mg dose. On-demand use means no daily commitment. If desire is the limiting factor — not mechanics — PT-141 is the starting point.
Our free Protocol Guide includes the complete hormonal optimization section — PT-141, Kisspeptin, Gonadorelin, and hormonal blood work panels.